Bioptik Technology Incorporation (TPEX:4161)
Taiwan
· Delayed Price · Currency is TWD 30.85
0.00 (0.00%)
May 29, 2025, 1:02 PM CST
TPEX:4161 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 865.34 | 828.5 | 767.75 | 737.89 | 485.6 | Upgrade
|
| Revenue Growth (YoY) | 4.45% | 7.91% | 4.05% | 51.95% | -14.27% | Upgrade
|
| Cost of Revenue | 597.43 | 588.96 | 590.29 | 574.35 | 402.44 | Upgrade
|
| Gross Profit | 267.91 | 239.54 | 177.46 | 163.55 | 83.16 | Upgrade
|
| Selling, General & Admin | 102.56 | 77.83 | 79.9 | 79.17 | 76.78 | Upgrade
|
| Research & Development | 75.35 | 71.47 | 58.3 | 48.94 | 50.15 | Upgrade
|
| Operating Expenses | 178.07 | 149.59 | 137.99 | 127.82 | 125.39 | Upgrade
|
| Operating Income | 89.84 | 89.95 | 39.48 | 35.73 | -42.23 | Upgrade
|
| Interest Expense | -9.13 | -11 | -9.19 | -7.82 | -8.47 | Upgrade
|
| Interest & Investment Income | 8.99 | 10.7 | 4.01 | 1.36 | 4.14 | Upgrade
|
| Currency Exchange Gain (Loss) | 13.32 | 4.95 | 29.94 | -9.45 | -15.58 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.57 | 3.14 | 4.62 | 5.52 | 9.52 | Upgrade
|
| EBT Excluding Unusual Items | 106.58 | 97.75 | 68.86 | 25.34 | -52.62 | Upgrade
|
| Gain (Loss) on Sale of Investments | 4.63 | 8.69 | -6.14 | -5.72 | -5.6 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.9 | 0.02 | 0.06 | 0 | 0.07 | Upgrade
|
| Asset Writedown | - | - | - | - | -5.65 | Upgrade
|
| Other Unusual Items | - | 0.02 | 0.03 | - | 0.1 | Upgrade
|
| Pretax Income | 110.32 | 106.47 | 62.81 | 19.62 | -63.69 | Upgrade
|
| Income Tax Expense | 17.98 | 21.89 | 15.78 | -0.94 | -1.48 | Upgrade
|
| Earnings From Continuing Operations | 92.34 | 84.58 | 47.03 | 20.56 | -62.21 | Upgrade
|
| Minority Interest in Earnings | 1.23 | 1.13 | 1.47 | 2.04 | 2.23 | Upgrade
|
| Net Income | 93.57 | 85.71 | 48.5 | 22.59 | -59.99 | Upgrade
|
| Net Income to Common | 93.57 | 85.71 | 48.5 | 22.59 | -59.99 | Upgrade
|
| Net Income Growth | 9.17% | 76.73% | 114.67% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 51 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 51 | 51 | 51 | 51 | Upgrade
|
| Shares Change (YoY) | 1.18% | 0.77% | 0.33% | 0.15% | -0.01% | Upgrade
|
| EPS (Basic) | 1.84 | 1.68 | 0.96 | 0.45 | -1.18 | Upgrade
|
| EPS (Diluted) | 1.80 | 1.67 | 0.95 | 0.45 | -1.18 | Upgrade
|
| EPS Growth | 7.78% | 75.35% | 113.67% | - | - | Upgrade
|
| Free Cash Flow | 143.9 | 175.53 | 38.13 | -60.29 | -6.46 | Upgrade
|
| Free Cash Flow Per Share | 2.77 | 3.42 | 0.75 | -1.19 | -0.13 | Upgrade
|
| Dividend Per Share | 0.300 | 0.700 | - | 0.286 | 0.286 | Upgrade
|
| Dividend Growth | -57.14% | - | - | - | -50.00% | Upgrade
|
| Gross Margin | 30.96% | 28.91% | 23.11% | 22.16% | 17.13% | Upgrade
|
| Operating Margin | 10.38% | 10.86% | 5.14% | 4.84% | -8.70% | Upgrade
|
| Profit Margin | 10.81% | 10.35% | 6.32% | 3.06% | -12.35% | Upgrade
|
| Free Cash Flow Margin | 16.63% | 21.19% | 4.97% | -8.17% | -1.33% | Upgrade
|
| EBITDA | 120.11 | 119.73 | 67.73 | 67.29 | -9.44 | Upgrade
|
| EBITDA Margin | 13.88% | 14.45% | 8.82% | 9.12% | -1.94% | Upgrade
|
| D&A For EBITDA | 30.27 | 29.78 | 28.25 | 31.57 | 32.79 | Upgrade
|
| EBIT | 89.84 | 89.95 | 39.48 | 35.73 | -42.23 | Upgrade
|
| EBIT Margin | 10.38% | 10.86% | 5.14% | 4.84% | -8.70% | Upgrade
|
| Effective Tax Rate | 16.30% | 20.56% | 25.12% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.